Calcium folinate pentahydrate
HER2-positive Advanced Breast Cancer
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)Small moleculePhase 1Active
CC
43/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 28/ 100
- Competitive Position
- 89/ 100
Competitive context
4 Active assets in the HER2-positive Advanced Breast Cancer cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Ribociclib Danish Breast Cancer Cooperative Group | Phase 3 | BB |
LEUPROLIDE Fudan University | Phase 2 | BB |
Inetetamab Fudan University | Phase 2/3 | B |
TQB2930 for injection Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. | Phase 3 | B |
bat8001 Bio-Thera Solutions | Phase 3 | B |
Same molecule, other indications
Calcium folinate pentahydrate is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →